Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05999799
What this trial is testing

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 161
Testing effectiveness (Phase 2)Active Not RecruitingNCT07105488
What this trial is testing

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc. 225
Not applicableEnded earlyNCT02634905
What this trial is testing

Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months

Who this might be right for
Dermatitis, Atopic
Nantes University Hospital 178
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891
What this trial is testing

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 520
Testing effectiveness (Phase 2)Study completedNCT03706040
What this trial is testing

Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis
AbbVie 172
Testing effectiveness (Phase 2)Ended earlyNCT01605708
What this trial is testing

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Regeneron Pharmaceuticals 19
Early research (Phase 1)Not Yet RecruitingNCT07801612
What this trial is testing

A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Health Adult SubjectsModerate-to-Severe Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd 68
Testing effectiveness (Phase 2)Looking for participantsNCT07445919
What this trial is testing

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 200
Large-scale testing (Phase 3)Ended earlyNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Testing effectiveness (Phase 2)WithdrawnNCT05240300
What this trial is testing

Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
BiomX, Inc.
Early research (Phase 1)Study completedNCT03826901
What this trial is testing

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Who this might be right for
Atopic Dermatitis
LEO Pharma 46
Large-scale testing (Phase 3)Study completedNCT03985943
What this trial is testing

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 941
Testing effectiveness (Phase 2)Looking for participantsNCT05995964
What this trial is testing

Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 340
Large-scale testing (Phase 3)Study completedNCT05704738
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 532
Large-scale testing (Phase 3)Ended earlyNCT05732454
What this trial is testing

Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedEczema+1 more
Pfizer 58
Testing effectiveness (Phase 2)Ended earlyNCT06881251
What this trial is testing

JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 256
Large-scale testing (Phase 3)Looking for participantsNCT07765888
What this trial is testing

Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 375
Large-scale testing (Phase 3)Study completedNCT03720470
What this trial is testing

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Who this might be right for
DermatitisDermatitis, AtopicEczema+7 more
Pfizer 838
Testing effectiveness (Phase 2)Study completedNCT03568136
What this trial is testing

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

Who this might be right for
Dermatitis, AtopicEczema, AtopicNeurodermatitis, Atopic
GWT-TUD GmbH 22
Testing effectiveness (Phase 2)Study completedNCT05923099
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 262
Next Page